The National Institute on Aging (NIA) Imbedded Pragmatic Alzheimer’s Disease (AD) and AD-Related Dementias (AD/ADRD) Clinical Trials (IMPACT) Collaboratory (U54AG063546) is pleased to announce a new request for applications for the 2023 Career Development Award (CDA). These CDAs support the development of MD, PhD, or equivalent researchers who seek careers conducting embedded pragmatic clinical trials (ePCTs) for people living with AD/ADRD and their care partners.
May 30, 2023 @ 2pm ET
Application Period Opens:
May 31, 2023
September 15, 2023 @ 5pm ET
This mechanism will fund research projects that are preparatory to conducting a future ePCT such as secondary data analysis, intervention development or the development of pragmatic outcomes. The proposed CDA project cannot include a clinical trial (including pilot trials; see NIH definition of a clinical trial). The IMPACT Collaboratory will fund up to two 1-year CDAs, prioritizing applications that address dementia care for people of all backgrounds and promote health equity. Each award will provide $100,000 annually in direct costs with an indirect cost rate capped at 8%. Awardees are required to devote a minimum of 75% effort toward the goals of the award. Applicants are typically within 7 years of their post-doctoral training program at the time of application. Exceptions will be made in this round of funding for investigators with more than 7 years who can demonstrate evidence of changing their career path to pursue research on ePCTs among PLWD. Such applicants must request prior approval.
A set of frequently asked questions (FAQ) regarding this award is available online at https://impactcollaboratory.org/CDA-grant-faq/. Click here to learn about previous awardees. Email IMPACTcollaboratory@hsl.harvard.edu with questions.